Saturday – Plenary Session 3

Full Name(Required)
Enter your first and last names as you would like them to appear on your certificates.
Enter the email you used to register for TOXINS 2026.

Please evaluate the speakers

Topic and Speaker(s)
ExcellentGoodFairPoor
Welcome Back
David Simpson, MD (USA)
Questions about BoNT you were afraid to ask
Panel
Announcement and award of the Best Basic Science Abstract
Giampietro Schiavo, PhD, FMedSci, FRSB (UK)
Announcement and award of the Best Clinical Abstract
Katharine Alter, MD (USA)
Once upon a dish: The next frontier in engineering multicellular systems
András Lakatos, MD, PhD, MRCP (UK)
Clinical Lifetime Achievement Award Presentation & Lecture
David Simpson, MD (USA)
Basic Science Lifetime Achievement Award Presentation & Lecture
Giampietro Schiavo, PhD, FMedSci, FRSB (UK)
Closing Remarks
Katharine Alter, MD (USA)
YesNo
Welcome Back
David Simpson, MD (USA)
Questions about BoNT you were afraid to ask
Panel
Announcement and award of the Best Basic Science Abstract
Giampietro Schiavo, PhD, FMedSci, FRSB (UK)
Announcement and award of the Best Clinical Abstract
Katharine Alter, MD (USA)
Once upon a dish: The next frontier in engineering multicellular systems
András Lakatos, MD, PhD, MRCP (UK)
Clinical Lifetime Achievement Award Presentation & Lecture
David Simpson, MD (USA)
Basic Science Lifetime Achievement Award Presentation & Lecture
Giampietro Schiavo, PhD, FMedSci, FRSB (UK)
Closing Remarks
Katharine Alter, MD (USA)
YesNo
Welcome Back
David Simpson, MD (USA)
Questions about BoNT you were afraid to ask
Panel
Announcement and award of the Best Basic Science Abstract
Giampietro Schiavo, PhD, FMedSci, FRSB (UK)
Announcement and award of the Best Clinical Abstract
Katharine Alter, MD (USA)
Once upon a dish: The next frontier in engineering multicellular systems
András Lakatos, MD, PhD, MRCP (UK)
Clinical Lifetime Achievement Award Presentation & Lecture
David Simpson, MD (USA)
Basic Science Lifetime Achievement Award Presentation & Lecture
Giampietro Schiavo, PhD, FMedSci, FRSB (UK)
Closing Remarks
Katharine Alter, MD (USA)
Strongly disagreeDisagreeNeutralAgreeStrongly agree
Ability to evaluate the latest clinical and scientific research into botulinum neurotoxins
Understanding of the clinical utility of botulinum neurotoxins
Understanding of potential new therapeutic applications of botulinum neurotoxins
Biomedical knowledge of botulinum and other neurotoxins and their application in enhancing therapeutics and improving care

Scam Warning

Due to scam emails being sent, please note that INA will NOT email you to wire money to anyone on the Board of Directors or anyone else from the INA.

Join Our Mailing List

Click here to sign up, and then manage your subscription.